Clinical Research Directory
Browse clinical research sites, groups, and studies.
Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)
Sponsor: University of California, Los Angeles
Summary
The purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.
Key Details
Gender
All
Age Range
2 Years - Any
Study Type
EXPANDED_ACCESS
Enrollment
Not specified
Start Date
Not specified
Completion Date
Not specified
Last Updated
2026-04-20
Healthy Volunteers
Not specified
Conditions
Interventions
Fenfluramine
The treatment plan for this Expanded Access Protocol is for patients with Dravet syndrome who do not qualify for participation in one of the ongoing ZX008 (fenfluramine hydrochloride) clinical trials.
Locations (1)
University of California, Los Angeles
Los Angeles, California, United States